Table of Content - Assisted Reproductive Technology Market Size, Growth To 2032

Assisted Reproductive Technology Market Segmentation

Assisted Reproductive Technology Diagnosis Outlook (USD Billion, 2019-2030)

Ovulation Testing

Hysterosalpingography

Assisted Reproductive Technology Type Outlook (USD Billion, 2019-2030)

Ovulation Induction

Artificial Insemination

Surrogacy

Assisted Reproductive Technology End-User Outlook (USD Billion, 2019-2030)

Hospitals

Clinics

IVF Center

Assisted Reproductive Technology Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)
- North America Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- North America Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- North America Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- US Outlook (USD Billion, 2019-2030)
- US Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- US Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- US Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- CANADA Outlook (USD Billion, 2019-2030)
- CANADA Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- CANADA Assisted Reproductive TechnologyBy Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- CANADA Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center

Europe Outlook (USD Billion, 2019-2030)
- Europe Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Europe Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Europe Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Germany Outlook (USD Billion, 2019-2030)
- Germany Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Germany Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Germany Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- France Outlook (USD Billion, 2019-2030)
- France Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- France Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- France Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- UK Outlook (USD Billion, 2019-2030)
- UK Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- UK Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- UK Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- ITALY Outlook (USD Billion, 2019-2030)
- ITALY Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- ITALY Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- ITALY Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- SPAIN Outlook (USD Billion, 2019-2030)
- Spain Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Spain Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Spain Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Rest Of Europe Outlook (USD Billion, 2019-2030)
- Rest Of Europe Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- REST OF EUROPE Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- REST OF EUROPE Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center

Asia-Pacific Outlook (USD Billion, 2019-2030)
- Asia-Pacific Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Asia-Pacific Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Asia-Pacific Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- China Outlook (USD Billion, 2019-2030)
- China Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- China Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- China Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Japan Outlook (USD Billion, 2019-2030)
- Japan Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Japan Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Japan Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- India Outlook (USD Billion, 2019-2030)
- India Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- India Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- India Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Australia Outlook (USD Billion, 2019-2030)
- Australia Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Australia Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Australia Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Rest of Asia-PacificOutlook (USD Billion, 2019-2030)
- Rest of Asia-Pacific Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Rest of Asia-Pacific Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Rest of Asia-Pacific Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center

Rest of the World Outlook (USD Billion, 2019-2030)
- Rest of the World Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Rest of the World Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Rest of the World Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Middle East Outlook (USD Billion, 2019-2030)
- Middle East Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Middle East Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Middle East Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Africa Outlook (USD Billion, 2019-2030)
- Africa Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Africa Assisted Reproductive Technology By Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Africa Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center
- Latin America Outlook (USD Billion, 2019-2030)
- Latin America Assisted Reproductive Technology By Diagnosis
  - Ovulation Testing
  - Hysterosalpingography
- Latin America Assisted Reproductive TechnologyBy Type
  - Ovulation Induction
  - Artificial Insemination
  - Surrogacy
- Latin America Assisted Reproductive Technology by End User
  - Hospitals
  - Clinics
  - IVF Center

Research Methodology on Assisted Reproductive Technology Market

Introduction

This research proposes to study the global assisted reproductive technology (ART) market. The objective of this research is to provide a comprehensive analysis of the market size, share, and dynamics of the industry. Secondary as well as primary research methods and techniques are applied to determine the exact size and growth trends. The global assisted reproductive technology market is segmented based on types, applications and services.

Research Objectives

The general objective of this research is to analyze the size, structure and growth of the global assisted reproductive technology market. The research focuses on the following objectives:

To analyze the market size and share in terms of revenue

To identify the key trends and drivers that impact the industry

To analyze the segment projections and understand market dynamics

To identify and analyze the major factors affecting the growth of the industry

Research Approach

The global assisted reproductive technology market is studied using both primary and secondary research methodologies. The study uses a combined approach of both quantitative and qualitative data analysis. Top-down and bottom-up approaches are used for the estimation and projection of the market size. Data such as market size, product types, applications, services and market segmentations have been collected from secondary sources such as industry reports, whitepapers and commercial databases, and primary sources such as interviews, surveys and in-depth analysis from industry experts.

Secondary Data

To understand the global assisted reproductive technology market, the report uses extensive secondary research. The report uses data such as market size, industry outlook and trends, applications, service providers, regulations and government incentives. The report also uses internal and external proprietary databases. The sources used to collect data include industry magazines, Internet searches, databases and financial statements.

Primary Data

For a deeper and more accurate understanding of the trends and dynamics, the report also employs primary research by interviewing industry professionals and stakeholders. Primary research includes interviews with industry experts and professionals. Experts from various industries and different countries are contacted to get their opinion on the global assisted reproductive technology market. Primary research includes surveys, email interactions and direct interviews with experts. The primary research provides a better understanding of the market trends, dynamics and any other insights that require in-depth analysis.

Data Analysis and Projection

All the data collected from both primary and secondary sources is analysed to provide an accurate overall picture of the market. The data is then used to project the market size and segmentation. Both top-down and bottom-up approaches are used to estimate the market size and metrics. Furthermore, the projection is also identified using regression analysis, ARIMA and ARMA models.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Assisted Reproductive Technology (ART) Market, by Diagnosis

6.1 Introduction

6.2 Ovulation Testing

6.3 Hysterosalpingography.

6.4 Ovarian Reserve Testing

6.5 Genetic Testing

6.6 Other hormone testing

6.7 Imaging tests

Chapter 7. Global Assisted Reproductive Technology (ART) Market, by Type

7.1 Introduction

7.2 Ovulation Induction (OI)

7.3 Artificial Insemination (AI)

7.4 Donor Conception

7.5 In-Vitro Fertilization (IVF)

7.6 Gamete Intrafallopian Transfer (GIFT)

7.7 Intracytoplasmic Sperm Injection (ICSI)

7.8 Preimplantation Genetic Diagnosis (PGD)

7.9 Surrogacy

Chapter 8. Global Assisted Reproductive Technology (ART) market, by End-User

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Ambulatory Surgical Centers

8.4 Diagnostic Centers

8.5 Gynecology Centers

8.6 Feminist Health Centers

8.7 IVF Centers

Chapter 9. Global Assisted Reproductive Technology (ART) Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Cosmos Biomedical Limited

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.2.4 Key Developments

11.1.5 SWOT Analysis

11.2 California Cryobank

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bloom IVF Centre

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Cryolab Ltd

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Parallabs

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 OvaScience

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Anecova

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Merck KGaA

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 CooperSurgical Inc.

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Ferring Pharmaceuticals

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 European Sperm Bank

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Irvine Scientific

11.12.1 Overview

11.12.2 Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Hamilton Throne Ltd

11.13.1 Overview

11.13.2 Type Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Microm Ltd

11.14.1 Overview

11.14.2 Type Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Others

Chapter 12 Appendix

LIST OF TABLES

Table 1 Assisted Reproductive Technology (ART) Market Industry Synopsis, 2023-2030

Table 2 Global Assisted Reproductive Technology (ART) Market Estimates & Forecast, 2023-2030, (USD Million)

Table 3 Global Assisted Reproductive Technology (ART) Market, by Region, 2023-2030, (USD Million)

Table 4 Global Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 5 Global Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 6 Global Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 7 North America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 8 North America Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 9 North America Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 10 US Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 11 US Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 12 US Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 13 Canada Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 14 Canada Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 15 Canada Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 16 South America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 17 South America Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 18 South America Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 19 Europe Assisted Reproductive Technology (ART) Market, Diagnosis, 2023-2030, (USD Million)

Table 20 Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 21 Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 22 Western Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 23 Western Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 24 Western Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 25 Eastern Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table26 Eastern Europe Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 27 Eastern Europe Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 28 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 29 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 30 Asia-Pacific Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

Table 31 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Diagnosis, 2023-2030, (USD Million)

Table 32 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Type, 2023-2030, (USD Million)

Table 33 Middle East & Africa Assisted Reproductive Technology (ART) Market, by End-User, 2023-2030, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Assisted Reproductive Technology (ART) Market

Figure 3 Market Dynamics for Global Assisted Reproductive Technology (ART) Market

Figure 4 Global Assisted Reproductive Technology (ART) Market Share, by Diagnosis 2020

Figure 5 Global Assisted Reproductive Technology (ART) Market Share, by Type 2020

Figure 6 Global Assisted Reproductive Technology (ART) Market Share, by End-User, 2020

Figure 7 Global Assisted Reproductive Technology (ART) Market Share, by Region, 2020

Figure 8 North America Assisted Reproductive Technology (ART) Market Share, by Country, 2020

Figure 9 Europe Assisted Reproductive Technology (ART) Market Share, by Country, 2020

Figure 10 Asia-Pacific Assisted Reproductive Technology (ART) Market Share, by Country, 2020

Figure 11 Middle East & Africa Assisted Reproductive Technology (ART) Market Share, by Country, 2020

Figure 12 Global Assisted Reproductive Technology (ART) Market: Company Share Analysis, 2020 (%)

Figure 13 COSMOS BIOMEDICAL LIMITED: Key Financials

Figure 14 COSMOS BIOMEDICAL LIMITED: Segmental Revenue

Figure 15 COSMOS BIOMEDICAL LIMITED: Geographical Revenue

Figure 16 California Cryobank: Key Financials

Figure 17 California Cryobank: Segmental Revenue

Figure 18 California Cryobank: Geographical Revenue

Figure 19 Bloom IVF Centre: Key Financials

Figure 20 Bloom IVF Centre: Segmental Revenue

Figure 21 Bloom IVF Centre: Geographical Revenue

Figure 22 Cryolab Ltd: Key Financials

Figure 23 Cryolab Ltd: Segmental Revenue

Figure 24 Cryolab Ltd: Geographical Revenue

Figure 25 OvaScience: Key Financials

Figure 26 OvaScience: Segmental Revenue

Figure 27 OvaScience: Geographical Revenue

Figure 28 Parallabs: Key Financials

Figure 29 Parallabs: Segmental Revenue

Figure 30 Parallabs: Geographical Revenue

Figure 31 Anecova. : Key Financials

Figure 32 Anecova. : Segmental Revenue

Figure 33 Anecova. : Geographical Revenue

Figure 34 Merck KGaA: Key Financials

Figure 35 Merck KGaA: Segmental Revenue

Figure 36 Merck KGaA: Geographical Revenue

Figure 37 CooperSurgical Inc.: Key Financials

Figure 38 CooperSurgical Inc.: Segmental Revenue

Figure 39 CooperSurgical Inc.: Geographical Revenue

Figure 40 Ferring Pharmaceuticals: Key Financials

Figure 41 Ferring Pharmaceuticals: Segmental Revenue

Figure 42 Ferring Pharmaceuticals: Geographical Revenue

Figure 46 Irvine Scientific .: Key Financials

Figure 47 Irvine Scientific .: Segmental Revenue

Figure 48 Irvine Scientific .: Geographical Revenue

Figure 49 Hamilton Throne Ltd: Key Financials

Figure 50 Hamilton Throne Ltd: Segmental Revenue

Figure 51 Hamilton Throne Ltd: Geographical Revenue

Figure 52 Microm Ltd: Key Financials

Figure 53 Microm Ltd: Segmental Revenue

Figure 54 Microm Ltd: Geographical Revenue

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights